A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.
Wang X, Haylock D, Hu CS, Kowalczyk W, Jiang T, Qiu J, Mosoyan G, He W, Marshall N, Mascarenhas J, Tarasova A, Brody J, Winkler D, Hoffman R.
Wang X, et al. Among authors: hoffman r.
Blood. 2016 Jun 30;127(26):3398-409. doi: 10.1182/blood-2015-10-674465. Epub 2016 Apr 25.
Blood. 2016.
PMID: 27114459
Free PMC article.